Trial Outcomes & Findings for Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening (NCT NCT04798664)
NCT ID: NCT04798664
Last Updated: 2026-02-25
Results Overview
The primary outcome measure is sustained abstinence for 6 months, and will require self-report of smoking cessation followed by biochemical confirmation at 2 weeks, 3, and 6 months.
COMPLETED
NA
3228 participants
6 months
2026-02-25
Participant Flow
Virtual outreach: 05/17/21-01/17/24. Potentially eligible patients received text messages and/or emails inviting them to complete an eligibility survey. Clinic outreach: 05/17/21-01/17/24. Patients who had not yet completed eligibility screening were handed an iPad with the enrollment URL when coming in for their LCDT appointment. Enrollment concluded on 01/31/24.
Eligible patients had the opportunity to review frequently asked questions and opt out of enrollment. Patients who neither opted out nor clicked 'Complete' to be randomized received an email and/or text message after 14 days, instructing them to notify the team if they did not wish to participate; otherwise, the patient was randomized three days later. This process was called 'last chance to opt out' (LCOO; 03/17/22-01/08/24).
Participant milestones
| Measure |
Basic Usual Care
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
|
Enhanced Usual Care Plus Financial Incentives
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.
Mobile Health Application: Episodic future thinking tool to overcome temporal discounting of future
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
605
|
889
|
889
|
845
|
|
Overall Study
COMPLETED
|
605
|
883
|
888
|
844
|
|
Overall Study
NOT COMPLETED
|
0
|
6
|
1
|
1
|
Reasons for withdrawal
| Measure |
Basic Usual Care
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
|
Enhanced Usual Care Plus Financial Incentives
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.
Mobile Health Application: Episodic future thinking tool to overcome temporal discounting of future
|
|---|---|---|---|---|
|
Overall Study
Death
|
0
|
6
|
1
|
1
|
Baseline Characteristics
Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening
Baseline characteristics by cohort
| Measure |
Basic Usual Care
n=605 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=889 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
|
Enhanced Usual Care Plus Financial Incentives
n=889 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=845 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.
Mobile Health Application: Episodic future thinking tool to overcome temporal discounting of future
|
Total
n=3228 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Continuous
|
60.9 years
STANDARD_DEVIATION 6.38 • n=24 Participants
|
61.6 years
STANDARD_DEVIATION 6.70 • n=20 Participants
|
61.6 years
STANDARD_DEVIATION 6.37 • n=40 Participants
|
61.7 years
STANDARD_DEVIATION 6.69 • n=565 Participants
|
61.5 years
STANDARD_DEVIATION 6.55 • n=349 Participants
|
|
Sex/Gender, Customized
Woman
|
337 participants
n=24 Participants
|
434 participants
n=20 Participants
|
440 participants
n=40 Participants
|
411 participants
n=565 Participants
|
1622 participants
n=349 Participants
|
|
Sex/Gender, Customized
Man
|
184 participants
n=24 Participants
|
283 participants
n=20 Participants
|
279 participants
n=40 Participants
|
255 participants
n=565 Participants
|
1001 participants
n=349 Participants
|
|
Sex/Gender, Customized
Self-describe
|
1 participants
n=24 Participants
|
2 participants
n=20 Participants
|
1 participants
n=40 Participants
|
5 participants
n=565 Participants
|
9 participants
n=349 Participants
|
|
Sex/Gender, Customized
Missing
|
83 participants
n=24 Participants
|
170 participants
n=20 Participants
|
169 participants
n=40 Participants
|
174 participants
n=565 Participants
|
596 participants
n=349 Participants
|
|
Sex: Female, Male
Female
|
384 Participants
n=24 Participants
|
521 Participants
n=20 Participants
|
530 Participants
n=40 Participants
|
513 Participants
n=565 Participants
|
1948 Participants
n=349 Participants
|
|
Sex: Female, Male
Male
|
221 Participants
n=24 Participants
|
368 Participants
n=20 Participants
|
359 Participants
n=40 Participants
|
332 Participants
n=565 Participants
|
1280 Participants
n=349 Participants
|
|
Race/Ethnicity, Customized
No
|
581 participants
n=24 Participants
|
803 participants
n=20 Participants
|
801 participants
n=40 Participants
|
756 participants
n=565 Participants
|
2941 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
Yes-Cuban
|
0 participants
n=24 Participants
|
3 participants
n=20 Participants
|
1 participants
n=40 Participants
|
4 participants
n=565 Participants
|
8 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
Yes-Mexican
|
3 participants
n=24 Participants
|
38 participants
n=20 Participants
|
44 participants
n=40 Participants
|
44 participants
n=565 Participants
|
129 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
Yes-Puerto Rican
|
18 participants
n=24 Participants
|
18 participants
n=20 Participants
|
24 participants
n=40 Participants
|
26 participants
n=565 Participants
|
86 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
Yes-Other
|
3 participants
n=24 Participants
|
27 participants
n=20 Participants
|
19 participants
n=40 Participants
|
15 participants
n=565 Participants
|
64 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaskan Native
|
0 participants
n=24 Participants
|
10 participants
n=20 Participants
|
2 participants
n=40 Participants
|
6 participants
n=565 Participants
|
18 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
Asian or Asian American
|
3 participants
n=24 Participants
|
26 participants
n=20 Participants
|
25 participants
n=40 Participants
|
23 participants
n=565 Participants
|
77 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
|
0 participants
n=24 Participants
|
2 participants
n=20 Participants
|
4 participants
n=40 Participants
|
2 participants
n=565 Participants
|
8 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
154 participants
n=24 Participants
|
238 participants
n=20 Participants
|
224 participants
n=40 Participants
|
207 participants
n=565 Participants
|
823 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
White or Caucasian
|
425 participants
n=24 Participants
|
552 participants
n=20 Participants
|
583 participants
n=40 Participants
|
549 participants
n=565 Participants
|
2109 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
Multiple
|
13 participants
n=24 Participants
|
22 participants
n=20 Participants
|
13 participants
n=40 Participants
|
20 participants
n=565 Participants
|
68 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
Other
|
9 participants
n=24 Participants
|
36 participants
n=20 Participants
|
35 participants
n=40 Participants
|
38 participants
n=565 Participants
|
118 participants
n=349 Participants
|
|
Race/Ethnicity, Customized
Decline
|
1 participants
n=24 Participants
|
3 participants
n=20 Participants
|
3 participants
n=40 Participants
|
0 participants
n=565 Participants
|
7 participants
n=349 Participants
|
|
Education
Did not graduate from high school
|
91 participants
n=24 Participants
|
107 participants
n=20 Participants
|
104 participants
n=40 Participants
|
91 participants
n=565 Participants
|
393 participants
n=349 Participants
|
|
Education
High school degree or equivalent
|
256 participants
n=24 Participants
|
348 participants
n=20 Participants
|
352 participants
n=40 Participants
|
344 participants
n=565 Participants
|
1300 participants
n=349 Participants
|
|
Education
Some college but no degree
|
102 participants
n=24 Participants
|
160 participants
n=20 Participants
|
148 participants
n=40 Participants
|
161 participants
n=565 Participants
|
571 participants
n=349 Participants
|
|
Education
Associate or Bachelor Degree
|
127 participants
n=24 Participants
|
223 participants
n=20 Participants
|
229 participants
n=40 Participants
|
210 participants
n=565 Participants
|
789 participants
n=349 Participants
|
|
Education
Graduate degree
|
29 participants
n=24 Participants
|
51 participants
n=20 Participants
|
56 participants
n=40 Participants
|
39 participants
n=565 Participants
|
175 participants
n=349 Participants
|
|
Income (%FPL)
0-199% Federal Poverty Line
|
307 participants
n=24 Participants
|
401 participants
n=20 Participants
|
418 participants
n=40 Participants
|
393 participants
n=565 Participants
|
1519 participants
n=349 Participants
|
|
Income (%FPL)
200-400+% Federal Poverty Line
|
295 participants
n=24 Participants
|
486 participants
n=20 Participants
|
466 participants
n=40 Participants
|
448 participants
n=565 Participants
|
1695 participants
n=349 Participants
|
|
Income (%FPL)
Missing
|
3 participants
n=24 Participants
|
2 participants
n=20 Participants
|
5 participants
n=40 Participants
|
4 participants
n=565 Participants
|
14 participants
n=349 Participants
|
|
Rurality (self-report)
Yes, rural
|
253 participants
n=24 Participants
|
325 participants
n=20 Participants
|
317 participants
n=40 Participants
|
308 participants
n=565 Participants
|
1203 participants
n=349 Participants
|
|
Rurality (self-report)
Don't know: Rural ZIP (not RUCA1)
|
12 participants
n=24 Participants
|
12 participants
n=20 Participants
|
12 participants
n=40 Participants
|
12 participants
n=565 Participants
|
48 participants
n=349 Participants
|
|
Rurality (self-report)
Don't know: RUCA1
|
46 participants
n=24 Participants
|
65 participants
n=20 Participants
|
76 participants
n=40 Participants
|
65 participants
n=565 Participants
|
252 participants
n=349 Participants
|
|
Rurality (self-report)
No, not rural
|
294 participants
n=24 Participants
|
487 participants
n=20 Participants
|
484 participants
n=40 Participants
|
460 participants
n=565 Participants
|
1725 participants
n=349 Participants
|
|
Tobacco/ Nicotine dependence
1-4
|
71 participants
n=24 Participants
|
109 participants
n=20 Participants
|
118 participants
n=40 Participants
|
111 participants
n=565 Participants
|
409 participants
n=349 Participants
|
|
Tobacco/ Nicotine dependence
5-7
|
77 participants
n=24 Participants
|
96 participants
n=20 Participants
|
105 participants
n=40 Participants
|
108 participants
n=565 Participants
|
386 participants
n=349 Participants
|
|
Tobacco/ Nicotine dependence
8-10
|
96 participants
n=24 Participants
|
182 participants
n=20 Participants
|
185 participants
n=40 Participants
|
178 participants
n=565 Participants
|
641 participants
n=349 Participants
|
|
Tobacco/ Nicotine dependence
11-20
|
264 participants
n=24 Participants
|
366 participants
n=20 Participants
|
340 participants
n=40 Participants
|
320 participants
n=565 Participants
|
1290 participants
n=349 Participants
|
|
Tobacco/ Nicotine dependence
21-30
|
73 participants
n=24 Participants
|
109 participants
n=20 Participants
|
103 participants
n=40 Participants
|
103 participants
n=565 Participants
|
388 participants
n=349 Participants
|
|
Tobacco/ Nicotine dependence
31 or more
|
24 participants
n=24 Participants
|
27 participants
n=20 Participants
|
38 participants
n=40 Participants
|
25 participants
n=565 Participants
|
114 participants
n=349 Participants
|
|
LDCT screening results
Concerning
|
248 Participants
n=24 Participants
|
255 Participants
n=20 Participants
|
259 Participants
n=40 Participants
|
232 Participants
n=565 Participants
|
994 Participants
n=349 Participants
|
|
LDCT screening results
Reassuring
|
357 Participants
n=24 Participants
|
634 Participants
n=20 Participants
|
630 Participants
n=40 Participants
|
613 Participants
n=565 Participants
|
2234 Participants
n=349 Participants
|
|
Number of prior LDCT screening tests (prior to enrollment)
|
1.64 number of scans
STANDARD_DEVIATION 1.63 • n=24 Participants
|
1.39 number of scans
STANDARD_DEVIATION 1.48 • n=20 Participants
|
1.39 number of scans
STANDARD_DEVIATION 1.49 • n=40 Participants
|
1.37 number of scans
STANDARD_DEVIATION 1.43 • n=565 Participants
|
1.43 number of scans
STANDARD_DEVIATION 1.50 • n=349 Participants
|
|
Presence of mental health diagnoses
Yes
|
289 Participants
n=24 Participants
|
384 Participants
n=20 Participants
|
431 Participants
n=40 Participants
|
382 Participants
n=565 Participants
|
1486 Participants
n=349 Participants
|
|
Presence of mental health diagnoses
No
|
312 Participants
n=24 Participants
|
495 Participants
n=20 Participants
|
449 Participants
n=40 Participants
|
457 Participants
n=565 Participants
|
1713 Participants
n=349 Participants
|
|
Presence of mental health diagnoses
Missing
|
4 Participants
n=24 Participants
|
10 Participants
n=20 Participants
|
9 Participants
n=40 Participants
|
6 Participants
n=565 Participants
|
29 Participants
n=349 Participants
|
|
Time of accrual
Enrolled on or before 9/18/2022 (pandemic era)
|
270 Participants
n=24 Participants
|
367 Participants
n=20 Participants
|
372 Participants
n=40 Participants
|
331 Participants
n=565 Participants
|
1340 Participants
n=349 Participants
|
|
Time of accrual
Enrolled after 9/18/2022
|
335 Participants
n=24 Participants
|
522 Participants
n=20 Participants
|
517 Participants
n=40 Participants
|
514 Participants
n=565 Participants
|
1888 Participants
n=349 Participants
|
|
Insurance
Commercial
|
310 Participants
n=24 Participants
|
453 Participants
n=20 Participants
|
468 Participants
n=40 Participants
|
437 Participants
n=565 Participants
|
1668 Participants
n=349 Participants
|
|
Insurance
Medicaid
|
95 Participants
n=24 Participants
|
119 Participants
n=20 Participants
|
105 Participants
n=40 Participants
|
94 Participants
n=565 Participants
|
413 Participants
n=349 Participants
|
|
Insurance
Medicare
|
198 Participants
n=24 Participants
|
315 Participants
n=20 Participants
|
313 Participants
n=40 Participants
|
309 Participants
n=565 Participants
|
1135 Participants
n=349 Participants
|
|
Insurance
Self-pay
|
0 Participants
n=24 Participants
|
0 Participants
n=20 Participants
|
1 Participants
n=40 Participants
|
2 Participants
n=565 Participants
|
3 Participants
n=349 Participants
|
|
Insurance
Missing
|
2 Participants
n=24 Participants
|
2 Participants
n=20 Participants
|
2 Participants
n=40 Participants
|
3 Participants
n=565 Participants
|
9 Participants
n=349 Participants
|
|
Have Smartphone with Internet
Yes
|
503 Participants
n=24 Participants
|
744 Participants
n=20 Participants
|
742 Participants
n=40 Participants
|
700 Participants
n=565 Participants
|
2689 Participants
n=349 Participants
|
|
Have Smartphone with Internet
No
|
102 Participants
n=24 Participants
|
145 Participants
n=20 Participants
|
147 Participants
n=40 Participants
|
145 Participants
n=565 Participants
|
539 Participants
n=349 Participants
|
|
Elixhauser Comorbidity Index (van Walraven)
|
3.60 units on a scale
STANDARD_DEVIATION 7.58 • n=24 Participants
|
3.11 units on a scale
STANDARD_DEVIATION 7.27 • n=20 Participants
|
3.31 units on a scale
STANDARD_DEVIATION 7.50 • n=40 Participants
|
3.57 units on a scale
STANDARD_DEVIATION 6.63 • n=565 Participants
|
3.38 units on a scale
STANDARD_DEVIATION 7.24 • n=349 Participants
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: Seven participants passed away prior to their quit ate assessment. One participant passed away after their 2-week lab assessment.
The primary outcome measure is sustained abstinence for 6 months, and will require self-report of smoking cessation followed by biochemical confirmation at 2 weeks, 3, and 6 months.
Outcome measures
| Measure |
Basic Usual Care
n=605 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=883 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=888 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=844 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Biochemically Confirmed Smoking Abstinence Sustained for 6 Months
|
26 Participants
|
45 Participants
|
78 Participants
|
61 Participants
|
SECONDARY outcome
Timeframe: 2 weeks, 3 months, 12 monthsPopulation: Seven participants passed away prior to their quit date assessment. One participant passed away after their 2-week lab assessment.
Rates of sustained biochemically confirmed smoking cessation
Outcome measures
| Measure |
Basic Usual Care
n=605 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=884 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=888 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=844 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Quit Status (Biochemically Confirmed)
2 weeks
|
58 Participants
|
85 Participants
|
133 Participants
|
90 Participants
|
|
Quit Status (Biochemically Confirmed)
3 months
|
37 Participants
|
56 Participants
|
100 Participants
|
74 Participants
|
|
Quit Status (Biochemically Confirmed)
12 months
|
23 Participants
|
35 Participants
|
62 Participants
|
40 Participants
|
SECONDARY outcome
Timeframe: BaselineThe EuroQuol Group's quality of life (EQ-5D-5L) scale is a 25-item validated scale used to assess patients' perceived health-related quality of life across the domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scale range: -1 to 1 index calculated from SAS package provided by author. Additionally calculating misery score which is sum of scores ranging from 5 to 25. For index, 1 is best possible health, while -1 are states worse than death. For the misery score, higher is worse health.
Outcome measures
| Measure |
Basic Usual Care
n=507 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=696 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=698 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=658 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Health-related Quality of Life
Raw Score
|
10.0 score on a scale
Standard Deviation 3.66
|
9.76 score on a scale
Standard Deviation 3.68
|
9.47 score on a scale
Standard Deviation 3.75
|
9.70 score on a scale
Standard Deviation 3.81
|
|
Health-related Quality of Life
Weighted Score
|
0.637 score on a scale
Standard Deviation 0.302
|
0.662 score on a scale
Standard Deviation 0.300
|
0.678 score on a scale
Standard Deviation 0.307
|
0.655 score on a scale
Standard Deviation 0.317
|
SECONDARY outcome
Timeframe: BaselineThe Challenges to Stopping Smoking Scale (CSS-21) is a validated 21-item measure to assess patients' perceived barriers to smoking cessation. The CSS-21 has two sub-scales: intrinsic factors (physical, psychological or cognitive aspects of quitting), 9 item intrinsic factors scale from 9-36, and extrinsic factors (social or environmental aspects of quitting), 12 item extrinsic factors scale from 12-43. Total score was also prepared, range 21-79. A higher score means a greater challenge.
Outcome measures
| Measure |
Basic Usual Care
n=478 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=667 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=664 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=624 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Perceived Barriers to Cessation
Total
|
49.4 score on a scale
Standard Deviation 10.2
|
49.3 score on a scale
Standard Deviation 11.1
|
49.3 score on a scale
Standard Deviation 11.5
|
49.2 score on a scale
Standard Deviation 11.7
|
|
Perceived Barriers to Cessation
Internal
|
24.4 score on a scale
Standard Deviation 5.47
|
24.6 score on a scale
Standard Deviation 5.76
|
24.5 score on a scale
Standard Deviation 5.84
|
24.5 score on a scale
Standard Deviation 6.19
|
|
Perceived Barriers to Cessation
External
|
25.0 score on a scale
Standard Deviation 6.27
|
24.7 score on a scale
Standard Deviation 6.77
|
24.8 score on a scale
Standard Deviation 6.98
|
24.7 score on a scale
Standard Deviation 6.79
|
SECONDARY outcome
Timeframe: BaselineWe will use the 10-item situational measure of self-efficacy related to smoking behavior. This scale measures how sure participants are that they can avoid smoking in different situations. The scale ranges from 10-40, with a higher score demonstrating more self-efficacy.
Outcome measures
| Measure |
Basic Usual Care
n=506 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=700 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=700 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=183 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Self-efficacy Related to Cessation Efforts
|
21.1 score on a scale
Standard Deviation 7.89
|
20.8 score on a scale
Standard Deviation 7.45
|
21.3 score on a scale
Standard Deviation 7.40
|
20.9 score on a scale
Standard Deviation 7.71
|
SECONDARY outcome
Timeframe: BaselineThe Stages of Change (SOC) is a validated 1-item measure to assess patient's self-reported motivation to quit.
Outcome measures
| Measure |
Basic Usual Care
n=509 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=707 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=710 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=670 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Motivation to Quit
No, not thinking of quitting
|
30 Participants
|
42 Participants
|
45 Participants
|
49 Participants
|
|
Motivation to Quit
Yes, within the next 6 months
|
209 Participants
|
332 Participants
|
346 Participants
|
295 Participants
|
|
Motivation to Quit
Yes, within the next 30 days
|
270 Participants
|
333 Participants
|
319 Participants
|
326 Participants
|
SECONDARY outcome
Timeframe: BaselineTemporal discounting is a measure of impulsivity that reflects people's tendencies to discount the value of a reward as a function of how far in the future it would be received. We will use the 5-Trial Adjusting Delay Task to assess temporal discounting. The scale ranges from 0.000110 to 24, with a higher value meaning present is valued more over future gain. K values were calculated in R using the values noted in Koffarnus \& Bickel 2014.
Outcome measures
| Measure |
Basic Usual Care
n=470 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=632 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=643 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=589 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Temporal ("Delay") Discounting
|
1.94 k value
Standard Deviation 6.04
|
1.67 k value
Standard Deviation 5.69
|
2.20 k value
Standard Deviation 6.43
|
1.84 k value
Standard Deviation 5.94
|
SECONDARY outcome
Timeframe: 6 monthsThe EuroQuol Group's quality of life (EQ-5D-5L) scale is a 25-item validated scale used to assess patients' perceived health-related quality of life across the domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scale range: -1 to 1 index calculated from SAS package provided by author. Additionally calculating misery score which is sum of scores ranging from 5 to 25. For index, 1 is best possible health, while -1 are states worse than death. For the misery score, higher is worse health.
Outcome measures
| Measure |
Basic Usual Care
n=236 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=340 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=355 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=287 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Health-related Quality of Life
Raw Score
|
10.1 score on a scale
Standard Deviation 3.61
|
9.66 score on a scale
Standard Deviation 3.86
|
9.62 score on a scale
Standard Deviation 3.72
|
9.81 score on a scale
Standard Deviation 3.89
|
|
Health-related Quality of Life
Weighted Score
|
0.626 score on a scale
Standard Deviation 0.299
|
0.664 score on a scale
Standard Deviation 0.316
|
0.667 score on a scale
Standard Deviation 0.304
|
0.650 score on a scale
Standard Deviation 0.313
|
SECONDARY outcome
Timeframe: 6 monthsThe Challenges to Stopping Smoking Scale (CSS-21) is a validated 21-item measure to assess patients' perceived barriers to smoking cessation. The CSS-21 has two sub-scales: intrinsic factors (physical, psychological or cognitive aspects of quitting), 9 item intrinsic factors scale from 9-36, and extrinsic factors (social or environmental aspects of quitting), 12 item extrinsic factors scale from 12-43. Total score was also prepared, range 21-79. A higher score means a greater challenge.
Outcome measures
| Measure |
Basic Usual Care
n=230 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=332 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=349 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=278 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Perceived Barriers to Cessation
Total
|
44.9 score on a scale
Standard Deviation 12.0
|
45.6 score on a scale
Standard Deviation 11.9
|
44.5 score on a scale
Standard Deviation 12.1
|
42.8 score on a scale
Standard Deviation 12.0
|
|
Perceived Barriers to Cessation
Internal
|
22.2 score on a scale
Standard Deviation 6.30
|
22.5 score on a scale
Standard Deviation 6.28
|
22.1 score on a scale
Standard Deviation 6.46
|
21.4 score on a scale
Standard Deviation 6.55
|
|
Perceived Barriers to Cessation
External
|
22.7 score on a scale
Standard Deviation 6.89
|
23.1 score on a scale
Standard Deviation 7.00
|
22.4 score on a scale
Standard Deviation 6.96
|
21.4 score on a scale
Standard Deviation 6.53
|
SECONDARY outcome
Timeframe: 6 monthsWe will use the 10-item situational measure of self-efficacy related to smoking behavior. This scale measures how sure participants are that they can avoid smoking in different situations. The scale ranges from 10-40, with a higher score demonstrating more self-efficacy.
Outcome measures
| Measure |
Basic Usual Care
n=237 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=335 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=362 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=291 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Self-efficacy Related to Cessation Efforts
|
27.9 score on a scale
Standard Deviation 8.96
|
27.8 score on a scale
Standard Deviation 9.09
|
29.1 score on a scale
Standard Deviation 9.30
|
29.1 score on a scale
Standard Deviation 9.25
|
SECONDARY outcome
Timeframe: 6 monthsThe Stages of Change (SOC) is a validated 1-item measure to assess patient's self-reported motivation to quit.
Outcome measures
| Measure |
Basic Usual Care
n=231 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=323 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=337 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=280 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Motivation to Quit
No, not thinking of quitting
|
8 Participants
|
10 Participants
|
8 Participants
|
6 Participants
|
|
Motivation to Quit
Yes, within the next 6 months
|
104 Participants
|
121 Participants
|
134 Participants
|
108 Participants
|
|
Motivation to Quit
Yes, within the next 30 days
|
119 Participants
|
192 Participants
|
195 Participants
|
166 Participants
|
SECONDARY outcome
Timeframe: 6 monthsTemporal discounting is a measure of impulsivity that reflects people's tendencies to discount the value of a reward as a function of how far in the future it would be received. We will use the 5-Trial Adjusting Delay Task to assess temporal discounting. The scale ranges from 0.000110 to 24, with a higher value meaning present is valued more over future gain. K values were calculated in R using the values noted in Koffarnus \& Bickel 2014.
Outcome measures
| Measure |
Basic Usual Care
n=216 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=296 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=325 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=254 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Temporal ("Delay") Discounting
|
3.31 k value
Standard Deviation 7.67
|
2.37 k value
Standard Deviation 6.43
|
2.34 k value
Standard Deviation 6.44
|
1.75 k value
Standard Deviation 5.42
|
SECONDARY outcome
Timeframe: 12 monthsThe EuroQuol Group's quality of life (EQ-5D-5L) scale is a 25-item validated scale used to assess patients' perceived health-related quality of life across the domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scale range: -1 to 1 index calculated from SAS package provided by author. Additionally calculating misery score which is sum of scores ranging from 5 to 25. For index, 1 is best possible health, while -1 are states worse than death. For the misery score, higher is worse health.
Outcome measures
| Measure |
Basic Usual Care
n=247 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=366 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=361 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=298 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Health-related Quality of Life
Raw Score
|
10.3 score on a scale
Standard Deviation 4.00
|
9.90 score on a scale
Standard Deviation 3.76
|
9.33 score on a scale
Standard Deviation 3.65
|
9.69 score on a scale
Standard Deviation 3.90
|
|
Health-related Quality of Life
Weighted Score
|
0.612 score on a scale
Standard Deviation 0.334
|
0.645 score on a scale
Standard Deviation 0.308
|
0.689 score on a scale
Standard Deviation 0.297
|
0.661 score on a scale
Standard Deviation 0.312
|
SECONDARY outcome
Timeframe: 12 monthsThe Challenges to Stopping Smoking Scale (CSS-21) is a validated 21-item measure to assess patients' perceived barriers to smoking cessation. The CSS-21 has two sub-scales: intrinsic factors (physical, psychological or cognitive aspects of quitting), 9 item intrinsic factors scale from 9-36, and extrinsic factors (social or environmental aspects of quitting), 12 item extrinsic factors scale from 12-43. Total score was also prepared, range 21-79. A higher score means a greater challenge.
Outcome measures
| Measure |
Basic Usual Care
n=238 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=359 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=348 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=292 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Perceived Barriers to Cessation
Total
|
45.0 score on a scale
Standard Deviation 11.07
|
45.5 score on a scale
Standard Deviation 12.1
|
43.1 score on a scale
Standard Deviation 11.5
|
44.0 score on a scale
Standard Deviation 13.1
|
|
Perceived Barriers to Cessation
Internal
|
22.4 score on a scale
Standard Deviation 6.21
|
22.5 score on a scale
Standard Deviation 6.34
|
21.5 score on a scale
Standard Deviation 6.39
|
21.8 score on a scale
Standard Deviation 6.98
|
|
Perceived Barriers to Cessation
External
|
22.6 score on a scale
Standard Deviation 6.83
|
23.0 score on a scale
Standard Deviation 6.90
|
21.6 score on a scale
Standard Deviation 6.36
|
22.1 score on a scale
Standard Deviation 7.22
|
SECONDARY outcome
Timeframe: 12 monthsWe will use the 10-item situational measure of self-efficacy related to smoking behavior. This scale measures how sure participants are that they can avoid smoking in different situations. The scale ranges from 10-40, with a higher score demonstrating more self-efficacy.
Outcome measures
| Measure |
Basic Usual Care
n=247 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=365 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=360 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=297 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Self-efficacy Related to Cessation Efforts
|
26.8 score on a scale
Standard Deviation 9.43
|
27.4 score on a scale
Standard Deviation 9.19
|
28.8 score on a scale
Standard Deviation 9.27
|
27.9 score on a scale
Standard Deviation 9.64
|
SECONDARY outcome
Timeframe: 12 monthsThe Stages of Change (SOC) is a validated 1-item measure to assess patient's self-reported motivation to quit.
Outcome measures
| Measure |
Basic Usual Care
n=241 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=355 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=341 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=296 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Motivation to Quit
Yes, within the next 6 months
|
104 Participants
|
144 Participants
|
133 Participants
|
123 Participants
|
|
Motivation to Quit
Yes, within the next 30 days
|
125 Participants
|
194 Participants
|
192 Participants
|
162 Participants
|
|
Motivation to Quit
No, not thinking of quitting
|
12 Participants
|
17 Participants
|
16 Participants
|
11 Participants
|
SECONDARY outcome
Timeframe: 12 monthsTemporal discounting is a measure of impulsivity that reflects people's tendencies to discount the value of a reward as a function of how far in the future it would be received. We will use the 5-Trial Adjusting Delay Task to assess temporal discounting. The scale ranges from 0.000110 to 24, with a higher value meaning present is valued more over future gain. K values were calculated in R using the values noted in Koffarnus \& Bickel 2014.
Outcome measures
| Measure |
Basic Usual Care
n=221 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=334 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=320 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=276 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Temporal ("Delay") Discounting
|
2.33 k value
Standard Deviation 6.30
|
1.79 k value
Standard Deviation 5.68
|
1.64 k value
Standard Deviation 5.39
|
1.47 k value
Standard Deviation 5.00
|
SECONDARY outcome
Timeframe: 2 weeks, 3 months, 6 months, 12 monthsPopulation: Seven participants passed away before their quit date assessment. One participant passed away after their 2 week lab assessment.
Rates of sustained self-reported cigarette abstinence
Outcome measures
| Measure |
Basic Usual Care
n=605 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=884 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=888 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=844 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Self-report Cigarette Abstinence
2 weeks
|
84 Participants
|
130 Participants
|
172 Participants
|
129 Participants
|
|
Self-report Cigarette Abstinence
3 months
|
46 Participants
|
66 Participants
|
114 Participants
|
79 Participants
|
|
Self-report Cigarette Abstinence
6 months
|
30 Participants
|
50 Participants
|
89 Participants
|
63 Participants
|
|
Self-report Cigarette Abstinence
12 months
|
25 Participants
|
40 Participants
|
64 Participants
|
45 Participants
|
SECONDARY outcome
Timeframe: 2 weeks, 3 months, 6 months, 12 monthsPopulation: Seven participants passed away before their quit date assessment. One participant passed away after their 2-week lab assessment.
Rates of sustained self-reported other tobacco abstinence
Outcome measures
| Measure |
Basic Usual Care
n=605 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
|
Enhanced Usual Care
n=884 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
|
Enhanced Usual Care Plus Financial Incentives
n=888 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
|
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=844 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
|
|---|---|---|---|---|
|
Self-report Other Tobacco Abstinence
6 months
|
30 Participants
|
50 Participants
|
89 Participants
|
63 Participants
|
|
Self-report Other Tobacco Abstinence
12 months
|
25 Participants
|
40 Participants
|
64 Participants
|
45 Participants
|
|
Self-report Other Tobacco Abstinence
2 weeks
|
81 Participants
|
130 Participants
|
169 Participants
|
127 Participants
|
|
Self-report Other Tobacco Abstinence
3 months
|
46 Participants
|
65 Participants
|
113 Participants
|
79 Participants
|
Adverse Events
Basic Usual Care
Enhanced Usual Care
Enhanced Usual Care Plus Financial Incentives
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place